Aethlon Medical (AEMD) Cash & Equivalents (2016 - 2024)
Aethlon Medical (AEMD) has disclosed Cash & Equivalents for 14 consecutive years, with $4.9 million as the latest value for Q4 2024.
- For the quarter ending Q4 2024, Cash & Equivalents fell 39.04% year-over-year to $4.9 million, compared with a TTM value of $4.9 million through Dec 2024, down 39.04%, and an annual FY2024 reading of $5.5 million, down 62.18% over the prior year.
- Cash & Equivalents was $4.9 million for Q4 2024 at Aethlon Medical, down from $6.9 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $25.2 million in Q2 2021 and bottomed at $4.9 million in Q4 2024.
- Average Cash & Equivalents over 5 years is $13.6 million, with a median of $13.7 million recorded in 2020.
- The sharpest move saw Cash & Equivalents skyrocketed 1742.18% in 2020, then plummeted 62.18% in 2024.
- Year by year, Cash & Equivalents stood at $12.2 million in 2020, then skyrocketed by 67.47% to $20.4 million in 2021, then dropped by 14.19% to $17.5 million in 2022, then plummeted by 53.94% to $8.1 million in 2023, then tumbled by 39.04% to $4.9 million in 2024.
- Business Quant data shows Cash & Equivalents for AEMD at $4.9 million in Q4 2024, $6.9 million in Q3 2024, and $9.2 million in Q2 2024.